Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Tandem Repeats Associated with Neurogenomic Somatic Instability and Neurodegeneration

Project description

Mapping DNA instability in dementia

Dementia and related neurodegenerative diseases are among the leading causes of disability worldwide. Despite their impact, the biological triggers of neuronal degeneration are poorly understood. Clues have emerged from rare genetic disorders caused by expansions of repetitive DNA sequences, known as tandem repeats, which can destabilise neurons. But their role in common, age-related diseases remains unclear. The EU-funded TRANSIT-ND project aims to investigate whether variations and instability in these DNA repeats contribute to widespread neurodegeneration. Using liquid biopsies, ultra-deep long-read sequencing and advanced brain imaging, researchers will map where instability occurs and how it affects neural circuits. By combining multi-omics analyses with laboratory validation, TRANSIT-ND aims to uncover shared mechanisms, and potential therapeutic targets, across major neurodegenerative disorders.

Objective

"Dementia and other neurodegenerative diseases are among the leading causes of disability worldwide and have an immense societal impact due to lack of effective treatments. For developing better preventive and therapeutic strategies, it is essential to clarify their still largely elusive genetic basis and pathophysiology. Emerging insights from the study of rare hereditary repeat expansion disorders caused by elongations of repetitive DNA sequences (""tandem repeats"" (TRs)) indicate that TRs could induce instability of neuronal DNA (""neurogenomic somatic instability""), and thereby instigate molecular changes that lead to neuronal degeneration. However, the role of highly prevalent TR variations or their somatic instability in the pathogenesis of common age-associated neurodegenerative diseases is unknown. Here, I aim to assess the role of TRs and their somatic instability in the pathogenesis of neuronal degeneration, the defining hallmark of all neurodegenerative diseases. To this end, I will 1) systematically identify TRs whose size or somatic instability are related to neuronal degeneration in the general population and/or disease severity in repeat expansion disorders, using an innovative approach combining ""liquid biopsy"" of neuronal tissue, high-throughput ultra-deep long-read DNA sequencing and ultrasensitive biomarkers of neuronal degeneration, 2) delineate the neuroanatomical pathways affected by TR somatic instability through comprehensive neuroimaging analyses, and 3) disentangle the underlying molecular and cellular mechanisms, using an extensive integrative multi-omics approach with experimental validation in neuronal cell lines and post-mortem human brain tissue. The wealth of unique insights from TRANSIT-ND could substantially increase our understanding of the pathogenesis of neuronal degeneration and provide shared targets for the prevention and treatment of a range of different neurodegenerative diseases that afflict millions of people globally."

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2021-STG

See all projects funded under this call

Host institution

DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV
Net EU contribution
€ 1 495 557,00
Address
VENUSBERG-CAMPUS 1/99
53127 Bonn
Germany
Region
Nordrhein-Westfalen Köln Bonn, Kreisfreie Stadt
Activity type
Research Organisations
Links
Total cost
€ 1 495 557,00

Beneficiaries (1)